« Back
Home /
Sotuletinib

Sotuletinib

Manufacturer	TargetMol
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Amount	500 mg
Item no.	TMO-T6119-500mg
CASRN	953769-46-5
eClass 6.1	30220300
eClass 9.0	32160605
Available
Alias	BLZ945
Short Description	Sotuletinib (BLZ945) is an orally active, effective and specific CSF-1R inhibitor (IC50: 1 nM), >1000-fold selective against its closest receptor tyrosine kinase homologs.
Shipping	cool pack
Storage	-20°
Target names or alias	BLZ945
Molecular Weight	398, 48
Pathway	Tyrosine Kinase/Adaptors
Target	CSF-1R\|\|\|c-Fms

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 500 mg

available

Delivery expected until 7/26/2024

Express Delivery: Save 3 days

Compare

Add to wishlist

Recommend by mail